Skip to main content
. 2004 Dec;42(12):5928–5930. doi: 10.1128/JCM.42.12.5928-5930.2004

TABLE 4.

Comparison of VITEK 2 MICs with reference MICs for the 72 levofloxacin-nonsusceptible isolates

Drug No. of VITEK 2 MICs that differed from reference MICsa
% EAb
−3 −2 −1 Same +1 +2 +3
Gatifloxacin 1 0 23 43 5 0 0 98.6
Moxifloxacin 1 0 11 41 18 1 0 97.2
a

Dilutions indicate the number of VITEK 2 MIC dilutions as compared to reference MICs.

b

EA, essential agreement (percent VITEK 2 MICs within one dilution of reference MICs).